A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss

—·5h

Vivani Medical is developing an implant of semaglutide, the active ingredient in Novo Nordisk's obesity injection Wegovy and diabetes counterpart Ozempic.

TickersGLPChannelsstocksCountriesusaCategoriesai-tech

Open original source ↗

Published

7/11/2026, 12:00:01 PM

Fetched

7/11/2026, 3:07:36 PM

Confidence

60 / 100

Relevance

35 / 100

Trust

—

Language